A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety

Edgar Sawatzky, Ehab Al-Momani, Ryohei Kobayashi, Takahiro Higuchi, Samuel Samnick, Michael Decker

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The enzyme butyrylcholinesterase (BChE) is known to be involved in the detoxification of xenobiotics in blood plasma and is associated with the progress of neurodegenerative disorders, diabetes type 2, obesity, and diseases of the cardiovascular system. In the present study, we developed carbamate-based inhibitors serving as positron emission tomography (PET) radiotracers with18F and11C as radioisotopes to visualize BChE distribution. These inhibitors are radiolabeled at the carbamate site and transfer this moiety onto BChE, which thus results in covalent and permanent radiolabeling of the enzyme. There are no comparable radiotracers for cholinesterases described to date. By ex vivo autoradiography experiments on mice brain slices and kinetic investigations, selective and covalent transfer of the radiolabeled carbamate moiety onto BChE was proven. These tracers might provide high resolution of BChE distribution in vivo to enable investigations into the pathophysiological mechanisms of diseases associated with alterations in BChE occurrence.

Original languageEnglish
Pages (from-to)1540-1550
Number of pages11
JournalChemMedChem
DOIs
Publication statusPublished - Jan 1 2016
Externally publishedYes

Keywords

  • carbamates
  • inhibitors
  • irreversible labeling
  • isotopic labeling
  • radiopharmaceuticals

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry

Fingerprint Dive into the research topics of 'A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety'. Together they form a unique fingerprint.

  • Cite this